What Does Revance Do?

Total employees647
HeadquartersNashville
Founded

Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings. The company is dedicated to advancing new standards in neuromodulator products for medical aesthetics and therapeutic applications. Revance's portfolio includes DAXXIFY® (DaxibotulinumtoxinA-lanm) for injection, the RHA® Collection of dermal fillers, and OPUL®, a Relational Commerce platform for aesthetics practices.

Where Is Revance's Headquarters?

Revance officeRevance officeRevance officeRevance office
*Images sourced via web search. Rights belong to original owners

HQ Function

The Nashville headquarters serves as the primary center for Revance's executive leadership, strategic planning, corporate operations, commercial activities, and investor relations.

Notable Features:

Located in a modern office building in Nashville's Gulch district, the headquarters offers contemporary workspaces designed to foster collaboration, innovation, and employee well-being.

Work Culture:

Revance fosters a work culture centered on innovation, scientific excellence, and a commitment to patients and customers. The environment is dynamic, encouraging cross-functional collaboration and agile decision-making to drive growth in the competitive biotech landscape.

HQ Significance:

The relocation to Nashville strategically positions Revance within a key U.S. healthcare ecosystem, providing access to a rich talent pool, fostering potential partnerships, and supporting its commercial expansion efforts.

Values Reflected in HQ: The headquarters' design and location likely reflect Revance's core values of innovation, collaboration, and a forward-thinking approach to advancing aesthetic and therapeutic medicine.

Location:

Revance Therapeutics primarily focuses its commercial operations on the United States market for its flagship products like DAXXIFY® and the RHA® Collection of dermal fillers. While direct international commercial operations are not extensive, the company sources its RHA® Collection through an exclusive U.S. distribution agreement with TEOXANE SA (Switzerland). Future global expansion for its proprietary products may be pursued through strategic partnerships or phased market entries.

Street Address:

1222 Demonbreun Street, Suite 2000

City:

Nashville

State/Province:

TN

Country:

USA

Where Else Does Revance Operate Around the World?

Newark, California/USA

Address: 7555 Gateway Boulevard, Newark, CA 94560

Located in the San Francisco Bay Area, this office leverages the region's dense concentration of biotech talent, research institutions, and venture capital, crucial for continued innovation and development.

Buying Intent Signals for Revance

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Revance? Meet the Executive Team

As of April 2025, Revance' leadership includes:

Mark J. Foley - President and Chief Executive Officer
Tobin C. Schilke - Chief Financial Officer
Dustin S. Sjuts - Chief Commercial Officer, Aesthetics & Therapeutics
Roman Rubio, M.D. - Head of Research and Development
David A. Hollander, M.D., M.B.A. - Chief Medical Officer
Dwight Moxie - General Counsel, Chief Compliance Officer & Corporate Secretary
Erika Marco - Chief People Officer

Who's Investing in Revance?

Revance has been backed by several prominent investors over the years, including:

BlackRock Inc.
The Vanguard Group, Inc.
RTW Investments, LP
EcoR1 Capital, LLC
Avoro Capital Advisors LLC
State Street Corporation
Perceptive Advisors LLC

What Leadership Changes Has Revance Seen Recently?

Hire3
Exits1

Revance Therapeutics has actively shaped its executive team over the past year, making key appointments to bolster its commercial, R&D, medical, and people operations capabilities. Notable additions include a new Chief People Officer, Head of Research and Development, and Chief Medical Officer. There was also a significant transition involving the former head of R&D and Product Operations moving into a consultancy role which later concluded.

Departures

Abhay Joshi, Ph.D., Abhay Joshi, Ph.D., concluded his consultancy engagement in December 2023, following his transition from President, R&D and Product Operations in June 2023.

New Appointments:

David A. Hollander, M.D., M.B.A., David A. Hollander, M.D., M.B.A. appointed as Chief Medical Officer.
Erika Marco, Erika Marco appointed as Chief People Officer.
Roman Rubio, M.D., Roman Rubio, M.D. appointed as Head of Research and Development.

What Technology (Tech Stack) Is Used byRevance?

Discover the tools Revance uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Revance Email Formats and Examples

Revance Therapeutics generally utilizes common corporate email formats. The most frequently observed pattern is a combination of the employee's first initial and last name, or first name and last name separated by a period, followed by '@revance.com'.

Common formats include [first_initial][last]@revance.com (e.g., jdoe@revance.com) and [first].[last]@revance.com (e.g., jane.doe@revance.com).

Format

jdoe@revance.com

Example

75%

Success rate

What's the Latest News About Revance?

Revance Therapeutics / Business Wire • May 7, 2024

Revance Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Revance announced its financial results for Q1 2024, highlighting revenue growth driven by DAXXIFY® and the RHA® Collection of fillers. The company also provided updates on its commercial strategy and product pipeline advancements....more

Revance Therapeutics / Business Wire • May 1, 2024

Revance Therapeutics Appoints David A. Hollander, M.D., M.B.A. as Chief Medical Officer

Revance announced the appointment of David A. Hollander, M.D., M.B.A., as its new Chief Medical Officer. Dr. Hollander will oversee medical affairs, clinical development, and pharmacovigilance....more

Revance Therapeutics / Business Wire • April 16, 2024

Revance Therapeutics Presents Positive Long-Term Data for DAXXIFY® in Cervical Dystonia at AAN Annual Meeting

Revance presented encouraging long-term efficacy and safety data from its ASPEN-1 OLE Phase 3 study of DAXXIFY® for treating cervical dystonia at the American Academy of Neurology (AAN) Annual Meeting....more

Revance Therapeutics / Business Wire • February 28, 2024

Revance Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

Revance reported its Q4 and full-year 2023 financial results, emphasizing the growth of DAXXIFY® and the RHA® Collection, and outlined its strategic priorities for 2024....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Revance, are just a search away.